Reliable Brokers
Online Investing
Alerts & Analysis
Easy Trading

CbdMD, YCBD, slumps 45% on pricing new stock issue - a proper horror

CbdMD has had a terrible time trying to raise more cash - the price dropped 23% on Froday, another 45% this morning

Update : 01 May 2023, 05:03 PM

CbdMD (NYSE: YCBD) has had a shocker of a weekend. The company is raising money - well, that's what stock markets are for, to finance companies. But the announcement that there would be a share offering was last week. At which point the price of YCBD dropped 23%. The actual pricing of the offer was made public this morning. At which point the shares dropped another 45%. This is not something that makes anyone happy, the company, the stockholders or, obviously, the underwriters. For the YCBD stock price is now firmly below the offering price. The offer's at $2.10 and the current stock price is $1.79. Just not a happy time.

It was only weeks ago that the company had a reverse stock split (45 for 1, which shows how the stock price has declined - down 89% over a year) to boost that price in nominal terms at least. But the rights issue - as Brits would call it, stock offering to Americans - was a pretty big ask anyway. With a market capitalisation around the $5 million mark attempting to raise another $2.8 million in cash is one of those big asks. Still, at least we can console ourselves with the thought that the underwriters are going to earn their money this time around. From the stock price before news of the issue it was priced at a 50% discount. May well have seemed safe enough even if that's not the way it turned out.

cbdMD stock price from NASDAQ

As to what cbdMD actually does as we might guess from the name it makes and distributes varied cannabidiol (CBD) products. There's a recent expansion into the UK market via Amazon for example. All of which is fine. But our contention here is that there simply aren't going to be any profits in the CBD market - nor the wider cannabis one as that gets legalised. There are simply too many people competing. Especially over something that can be grown as a weed in most gardens and to a high standard of quality under a simple grow light. That competition from the home produced market simply does, to our minds, mean there will never be significant profit margins here.

Top Brokers